Global Precision Medicine Market 2018-2024
25-May-2018 | Number of pages: 215 | Report Id: BMRC PH 123 | Report Format: | Status: Upcoming

Global Precision Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Brandessence Market Research is working on a new report titleGlobal Precision Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.The growth in the precision medicine market is propelled by an increasing demand for personalized treatment; technological innovation and advancement , as well as  growth of personal healthcare devices are major key factor which drives the Global Precision Medicine Market.

Scope of Global Precision Medicine Market Reports –

Precision medicine is often called as Personalized Medicine. It is used to describe how genetic information about a person’s disease is being used to diagnose or treat their disease. Precision Medicine refers to the modification of medical treatment to the individual characteristics of each patient. It does not exactly mean the manufacturing of drugs or medical devices that are unique to a patient, but the ability to categorize individuals into sub-populations that diverge in their susceptibility to a particular disease. Preventive or therapeutic interventions can then be focused on those who will benefit, sparing cost and side effects for those who will not. The main aim of government regulations is to make Precision Medicines more accepted and it is focused towards genetic diseases related to oncology, skin, respiratory, central nervous system, cardiovascular, and infectious diseases.

The key objective of Cancergenomics is to improve personalized medicine through the DNA sequencing and analysis of patient tumors cells to find out new genetic mutation associated with specific cancers.

Genetic information has helped to increase the development and use of the newest cancer treatments like Chemotherapy, Radiation Therapy, Targeted Therapy and Precision Medicines. For example, the drug Imatinib was modified to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenousleukemia. Another example is the breast cancer drug Trastuzumab which works only for women whose tumors have a particular genetic profile calledHuman Epidermal Growth Factor Receptor 2(HER-2 positive). It is also found that lung cancer patients whose tumors are positive forEstimated Glomerular Filtration Rate (EGFR)mutations will respond to the drugs Gefitinib and Erlotinib which target this mutation. Conversely, colon cancer patients whose tumors have a mutation in a gene called KRAS (K-RAS) derive less benefit from the drugs Cetuximab and Panitumumab. The genomic information made by The Cancer Genome Atlas (TCGA) will boostthe research to develop similar treatment strategies for a given set of genomic alterations.

Global Precision Medicine Market is segmented on the basis of Technology Type, Sequencing Technology, Product, Application, End User and Geography. On the Basis ofTechnology Type, Global Precision Medicine Market is classified asBig Data, Analytics, Bioinformatics, Gene Sequencing, Pharmacogenomics Companion Diagnostics and Others.On the basis of Sequencing Technology Global Precision Medicine Market is classified into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Legation, Pyro sequencing, Single Molecule Real Time Sequencing, Chain Termination and Nano pore Sequencing.On the basis of Product Global Precision Medicine Market is classified as Consumables, Instruments and Services.On the basis of Application Global Precision Medicine Market is classified as Oncology, Central Nervous System, Immunology, Respiratory medicinesNeurology, Endocrinology, Pulmonary diseases, Ophthalmology, Metabolic diseases, and Infectious.On the basis of end Users Global Precision Medicine Market is classified as Pharma and Biotechnology Companies, Diagnostics Companies, Healthcare Companies, IT Companies, Big Data Companies and Clinical laboratories.

The regions covered in Global Precision Medicine Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Precision Medicine Market Reports –

Global Precision Medicine Market reports cover prominent players likeAbbott Laboratories, GE Healthcare, GlaxoSmithKline (GSK), Johnson & Johnson, Pfizer, Laboratories Corporation of America Holdings, Danaher Corporation,Biocrates Life Sciences AG, Nanostring Technologies, Intomics, Ferrer Incode, Eagle Genomics Ltd, Teva Pharmaceuticals, Medtronic, Novartis, Qiagen, Quest Diagnostics,Thermo Fisher Scientific Inc., AstraZeneca, Bristol-Myers Squibb, Eli Lilly And Company, Illumina, Inc., Amgen, Inc., Astellas Pharma, bioMerieux SA, Epic Sciences, Gilead Sciences, Janssen Diagnostics, Precision For Medicines, Tepnel Pharma Services, Covance, Silicon Biosystems(now part of the Menarini Group), Roche Holding, Silicon Biosystems,Tepnel Pharma Services, Almac Group Ltd, Asuragen Inc., Cepheid Inc. and Cetics Healthcare Technologies GmbH.

Global Precision Medicine Market Dynamics –

The key drivers for Global Precision Medicine Market are improvement in personal healthcare, latest wireless technologies with portable healthcare devices and upsurge in genetic diseases due to mutation, UV rays among others.Also growing approval of drug along with its diagnostic assay, cheaper profiling of DNA, rising rate of various types of cancer are some of the reasons leading to the growth of the Global Precision Medicine Market.The keypurpose of these regulations is to make precision medicines more acceptable and focused to genetic diseases associated to Oncology, skin, respiratory, CNS, CVD and infectious diseases among others. The patients are profitedultimately by these regulations as it save time and cutting cost as the patients acquire the vital treatment for the specific disease.Now, the Global Precision Medicine Market is ahead due to the growth of personal healthcare devices like Nebulizer, Infusion Pump, Glucose Meter and integration of smart technologies in the healthcare system such as Digital Patient Room Whiteboards. In addition, growing associations and partnerships between various ecosystem players are supporting the healthy growth of the Global Precision Medicine Market. The Global Precision Medicine Market is driven by rising demand for personalized treatment, technological advancement.

The Global Precision Medicine Market restraintscomprises potential threat to personal data, high diagnostic cost  for e.g.,the cost for Orkambi oral tablet (125 mg-100 mg) is around $21,848 for a supply of 112 tablets, depending on the pharmacy is a barrier, potential risk of hardware or software failure, stringent regulations and standards. The improvement and innovation of novel healthcare technologies are emerging the platform for the growth of precision medicine market. The main aim of the government initiatives is toward oncology, but it is expected to target almost all therapeutic areas affected by genetic mutations.

Also, promising regulations are playing a key role in the growing rate of commercialization of novel molecule combinations and drug delivery techniques in the Global Precision Medicine Market sector. The advancements in drug development and the investigation of a large number of regulatory healthcare reforms, favoring development of methods for the improved diagnosis and treatment of chronic pain, will help the Global Precision Medicine Market tread along a promising growth path in the next few years.

Global Precision Medicine Market Regional Analysis –

Geographically, North America is leading the share in Global Precision Medicine Market.The growth of this regional market is mainly because of favorable reimbursement policies. The massive investment in the field of precision medicine in United State will generate the growth of the market within the calculated period. However the funding is for oncology targeted therapy, the research would gradually expand to other applications. North America is at the leading as far as the acceptance and consumption of precision medicine is concerned. Also Europe having a high position in the Global Precision Medicine Market.As economically developing regions such as Asia-Pacific are still behind the developed countries, this region has vast potential for market growth, and this region will show significant hike in the forecast period.Asia Pacific is likely to see the leading growth rate due to aincreasing geriatric population, growing awareness to health problems in and increased focus of leading companies to tap into growth opportunities in China and India.Furthermore, increase in awareness through various government and NGO campaigns of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

Key Benefits for Global Precision Medicine MarketReports –

  • Global Precision Medicine Market report covers in depth historical and forecast analysis.
  • Global Precision Medicine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Precision Medicine Market report helps to identify opportunities in market place.
  • Global Precision Medicine Market report covers extensive analysis of emerging trends and competitive landscape.

Global Precision Medicine Market Segmentation

Global Precision Medicine Market: By Technology Type Analysis

  • Big Data
  • Analytics
  • Bioinformatics
  • Gene Sequencing
  • Pharmacogenomics Companion Diagnostics
  • Others

Global Precision Medicine Market: By Sequencing Technology Analysis

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Legation
  • Pyro sequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination
  • Nano pore Sequencing
  • Others

Global Precision Medicine Market: By Product Analysis

  • Consumables
  • Instruments
  • Services
  • Others

Global Precision Medicine Market: By Application Analysis

  • Oncology
  • Central Nervous System
  • Immunology
  • Respiratory medicines Neurology
  • Endocrinology
  • Pulmonary diseases
  • Ophthalmology
  • Metabolic diseases
  • Infectious
  • Others

Global Precision Medicine Market: By End User Analysis

  • Pharma and Biotechnology Companies
  • Diagnostics Companies
  • Healthcare Companies
  • IT Companies
  • Clinical laboratories
  • Others

Global Precision Medicine Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Precision Medicine Market 2018-2024

Our 215 pages report provides 77 tables, 67 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Precision Medicine Market
  • To receive forecasts of Global Precision Medicine Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Precision Medicine Market sector
  • To determine the forces and factor that influences the market for Global Precision Medicine Market: drivers, restraints, opportunities and threats
  • To find out where the Global Precision Medicine Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

 

Global Precision Medicine Market: By Region Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

 

Global Precision Medicine Market: ByTechnology Type Analysis

 

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Big Data XX XX XX XX XX
Analytics XX XX XX XX XX
Bioinformatics XX XX XX XX XX
Gene Sequencing XX XX XX XX XX
Pharmacogenomics Companion Diagnostics XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Precision Medicine Market: By Sequencing TechnologyAnalysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Sequencing by Synthesis XX XX XX XX XX
Ion Semiconductor Sequencing XX XX XX XX XX
Sequencing by Legation XX XX XX XX XX
Pyro sequencing XX XX XX XX XX
Single Molecule Real Time Sequencing XX XX XX XX XX
Chain Termination XX XX XX XX XX
Nano pore Sequencing XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Precision Medicine Market: By Product Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Consumables XX XX XX XX XX
Instruments XX XX XX XX XX
Services XX XX XX XX XX
Others XX XX XX XX XX

 

Global Precision Medicine Market: By Application Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Oncology XX XX XX XX XX
Central Nervous System XX XX XX XX XX
Immunology XX XX XX XX XX
Respiratory medicines XX XX XX XX XX
Neurology
Endocrinology XX XX XX XX XX
Pulmonary diseases XX XX XX XX XX
Ophthalmology XX XX XX XX XX
Metabolic diseases XX XX XX XX XX
Infectious XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Precision Medicine Market: By End User Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Pharma and Biotechnology Companies

 

XX XX XX XX XX
Diagnostics Companies

 

XX XX XX XX XX
Healthcare Companies

 

XX XX XX XX XX
IT Companies

 

XX XX XX XX XX
Clinical Laboratories

 

XX XX XX XX XX
Others

 

XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

  • This report features news, insights, the latest developments and an in depth survey ofGlobal Precision Medicine Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • Abbott Laboratories
  • GE Healthcare
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Pfizer
  • Laboratories Corporation of America Holdings
  • Danaher Corporation
  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Intomics
  • Ferrer Incode
  • Eagle Genomics Ltd
  • Teva Pharmaceuticals
  • Medtronic
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly And Company
  • Illumina Inc.
  • Amgen Inc.
  • Astellas Pharma
  • bioMerieux SA
  • Epic Sciences
  • Gilead Sciences
  • Janssen Diagnostics
  • Precision For Medicines
  • Tepnel Pharma Services
  • Covance
  • Silicon Biosystems (now part of the Menarini Group)
  • Roche Holding
  • Silicon Biosystems
  • Tepnel Pharma Services
  • Almac Group Ltd
  • Asuragen Inc.
  • Cepheid Inc.
  • Cetics Healthcare Technologies GmbH
  • Others

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Precision Medicine Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Precision Medicine Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Precision Medicine Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Precision Medicine Market Overview: Quantitative Analysis
    • 2. Global Precision Medicine Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Precision Medicine Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Precision Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Precision Medicine Market: by Technology Type
  3. Chapter – Global Precision Medicine Market: by Sequencing Technology
  4. Chapter – Global Precision Medicine Market: by Product
  5. Chapter – Global Precision Medicine Market: by Application
  6. Chapter – Global Precision Medicine Market: by End User
    • Global Precision Medicine Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Precision Medicine Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Precision Medicine Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Precision Medicine Market Share (%), by Manufacturer, 2017
    • Global Precision Medicine Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Precision Medicine Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  7. Chapter – Global Precision Medicine Market: Regional Analysis
    • North America
    • North America Global Precision Medicine Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Precision Medicine Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Precision Medicine Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Precision Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Precision Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Precision Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  8. Chapter – Company Profiles
    • Abbot Laboratories
    • Overview
    • Financials
    • Product portfolio
  • Global Precision Medicine Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
  • Global Precision Medicine Market Share (%), 2014 – 2017
    • Business strategy
    • Recent developments
  • Pfizer Inc.
  • Janssen Biotech Inc.
  • Celgene Corporation
  • Glenmark Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Stiefel Laboratories Inc. (GlaxoSmithKline plc)
  • Novartis AG
  • Amgen Inc.
  • Biogen Idec
  • Johnson & Johnson
  • AstraZeneca
  • Boehringer Ingelheim
  • Sun Pharmaceuticals Industries Ltd
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Cipla Ltd
  • Rowan Bioceuticals Private Limited
  • LEO Pharma
  • G & W Laboratories Inc.
  • Win Medicare Pvt. Ltd
  • Merck and Co. Inc.
  • Abbvie Inc.
  • Others
  1. Chapter – Market Research and Findings

  • Abbott Laboratories
  • GE Healthcare
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Pfizer
  • Laboratories Corporation of America Holdings
  • Danaher Corporation
  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Intomics
  • Ferrer Incode
  • Eagle Genomics Ltd
  • Teva Pharmaceuticals
  • Medtronic
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly And Company
  • Illumina Inc.
  • Amgen Inc.
  • Astellas Pharma
  • bioMerieux SA
  • Epic Sciences
  • Gilead Sciences
  • Janssen Diagnostics
  • Precision For Medicines
  • Tepnel Pharma Services
  • Covance
  • Silicon Biosystems (now part of the Menarini Group)
  • Roche Holding
  • Silicon Biosystems
  • Tepnel Pharma Services
  • Almac Group Ltd
  • Asuragen Inc.
  • Cepheid Inc.
  • Cetics Healthcare Technologies GmbH
  • Others